Home›Stock Screener›Unichem Laboratories

Unichem Laboratories Share Price Today | Stock Price & Unichem Laboratories Share Screener

UNICHEMLAB Pharmaceuticals
Live Share Price NSE
₹531.45
▼ -3.60 (-0.67%)
2026-10-05 00:00:00
Live Share Price BSE
₹531.75
▼ -3.75 (-0.70%)
2026-10-05 00:00:00

As of October 5, 2026, the live Unichem Laboratories share price (NSE: UNICHEMLAB) is ₹531.45 on NSE and ₹531.75 on BSE, down 0.67% from the previous close, with shares trading between ₹512.00 and ₹545.00 in today's trading session, and a 52-week range of ₹284.05–₹650.60. Check UNICHEMLAB 52-week chart for the annual price range and momentum. Use the Unichem Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Unichem Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹648 and net income of ₹42, with EBITDA of ₹86, an operating margin of 11.0% and a profit margin of 6.5%.

Unichem Laboratories Market Cap ₹3,767.06 Cr.
UNICHEMLAB P/E Ratio (TTM) 12.62
Unichem Laboratories P/B Ratio 1.42
EPS (TTM) ₹35.91
Dividend Yield -
Debt to Equity 0.19
UNICHEMLAB 52 Week High ₹650.60
Unichem Laboratories 52 Week Low ₹284.05
Operating Margin 11.00%
Profit Margin 6.48%
UNICHEMLAB Revenue (TTM) ₹648.00
EBITDA ₹86.00
Net Income ₹42.00
Total Assets ₹3,737.00
Total Equity ₹2,717.00

Unichem Laboratories Share Price Chart

Track the current stock price of Unichem Laboratories with an interactive chart. Analyse UNICHEMLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Unichem Laboratories stock quote in one place.

The quote of ₹531.45 sits between the 52-week low of ₹284.05 and the 52-week high of ₹650.60, and the latest session moved -0.67% from the previous close.

Unichem Laboratories Company Profile - Fundamental Screener

Screen Unichem Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for UNICHEMLAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE351A01035.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE351A01035

Unichem Laboratories Balance Sheet Screener

Screen UNICHEMLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,737, up from ₹3,569 in 2025.

Latest statistics put total assets at ₹3,737 and shareholder funds at ₹2,717, with a leverage ratio of 0.19.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 3,737 3,569 3,275 3,193 3,319 3,126 3,145 3,150 3,194 1,527
Current Assets 2,197 2,030 1,743 1,589 1,648 1,377 1,687 2,038 2,337 749
Fixed Assets 1,213 1,300 1,252 1,257 990 884 870 810 578 491

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 134 127 99 118 148 63 47 27 50 70
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 2,717 2,451 2,438 2,435 2,618 2,557 2,531 2,620 2,680 1,064
Share Capital 14 14 14 14 14 14 14 14 14 18
Reserves & Surplus 2,703 2,437 2,424 2,421 2,604 2,543 2,517 2,606 2,666 1,045

Unichem Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Unichem Laboratories income statement and profit fundamentals. Analyze UNICHEMLAB quarterly results. Unichem Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹648 and net profit was ₹42, equal to earnings per unit of ₹5.89, at an operating margin of 11%.

In that period expenses were ₹563, interest cost ₹7 and tax ₹8. The next period listed, 2026-Mar, shows revenue of ₹599 and net profit of ₹11.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec

Revenue and Expenses

Revenue 648 599 809 600 533 596 547 516 487 438 545 421 432 407 319
Expenses 563 540 476 571 504 504 448 452 443 532 435 407 395 419 345

Operating Costs and Margins

EBITDA 86 59 332 29 29 93 99 64 44 -94 110 14 37 -12 -26
Operating Profit % 11.00% 6.00% 9.00% 1.00% 4.00% 14.00% 16.00% 11.00% 8.00% -23.00% 7.00% 2.00% 7.00% -4.00% -14.00%
Depreciation 30 31 31 32 32 30 31 32 32 27 32 30 29 30 31
Interest 7 9 7 8 7 6 7 5 4 5 6 7 6 6 4

Profit and Earnings

Profit Before Tax 49 19 293 -11 -9 58 62 27 8 -126 73 -22 2 -47 -61
Tax 8 8 29 1 1 5 4 3 6 3 0 3 3 -3 3
Net Profit 42 11 264 -12 -11 53 58 25 2 -129 73 -25 -1 -44 -64
EPS 5.89 1.55 37.54 -1.69 -1.49 7.52 8.22 3.50 0.29 -18.37 10.39 -3.48 -0.09 -6.28 -9.08

Unichem Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen UNICHEMLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹4, and net cash flow was an inflow of ₹200.

Over the same period, investing activities provided ₹194 and financing activities provided ₹2.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 4 -7 14 -85 -260 33 20 -328 -112 68
Investing Activities 194 -242 63 241 100 -66 -36 -286 1,648 -128

Financing and Net Cash

Financing Activities 2 184 -106 -81 191 -121 -62 -2 -881 59
Net Cash Flow 200 -65 -29 75 32 -154 -78 -616 655 -1

Unichem Laboratories Shareholding Pattern Screener

See Unichem Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Unichem Laboratories promoter holding and ownership changes for UNICHEMLAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 70.22%, foreign institutions 1.00%, domestic institutions 10.63% and the public 15.22%, spread across 23,386 shareholders.

The shareholder count was 23,386 in 2026-Mar, compared with 25,347 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 70.22% 70.22% 70.22% 70.22% 70.22% 70.22% 70.22% 70.22%

Institutional Investors

FII Holding 1.00% 0.90% 0.98% 0.98% 1.00% 0.99% 0.90% 0.89%
DII Holding 10.63% 10.46% 11.32% 10.92% 10.75% 10.74% 11.27% 11.58%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 15.22% 15.59% 14.80% 15.16% 15.26% 15.18% 15.12% 14.80%
Other Holding 2.93% 2.83% 2.67% 2.72% 2.77% 2.86% 2.49% 2.50%
Shareholder Count 23,386 25,347 21,621 23,010 23,577 23,267 21,171 20,621

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Unichem Laboratories. Unichem Laboratories dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹4.00 0.81%
2022-March ₹4.00 1.39%
2021-March ₹4.00 1.54%
2020-March ₹4.00 1.29%
2019-March ₹4.00 2.57%
2018-March ₹5.00 2.57%
2017-March ₹3.00 1.05%

Unichem Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Unichem Laboratories stock. Check UNICHEMLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

Unichem Laboratories Market Events Screener - Corporate Actions

Get Unichem Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Unichem Laboratories stock events that may affect UNICHEMLAB share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 11, 2026, with a record date of August 11, 2026.

It is followed by Annual General Meeting dated August 11, 2026 and Quarterly Result Announcement dated May 22, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-11 2026-08-11 Quarterly Result Announcement NA -6.07%
2026-08-11 2026-08-11 Annual General Meeting NA 34.15%
2026-05-22 2026-05-22 Quarterly Result Announcement NA -1.95%
2026-02-05 2026-02-05 Quarterly Result Announcement NA -1.58%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -1.98%
2025-08-04 2025-08-04 Annual General Meeting NA 6.72%
2025-08-04 2025-08-04 Quarterly Result Announcement NA 0.42%
2025-05-22 2025-05-22 Quarterly Result Announcement NA 7.30%
2025-02-06 2025-02-06 Quarterly Result Announcement NA 7.03%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 9.30%
2024-08-08 2024-08-08 Annual General Meeting NA 8.44%
2022-08-01 2022-08-03 Dividend ₹ 4.00 /share 26.80%
2021-07-22 2021-07-26 Dividend ₹ 4.00 /share -7.27%

Unichem Laboratories Competitors Screener - Peer Stocks Comparison

Screen UNICHEMLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Unichem Laboratories Company Announcements - News & Reports Screener

Screen UNICHEMLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 29, 2026.

The next most recent announcements are dated September 27, 2026 and September 19, 2026.

Date Update Actions
2026-09-29 Announcement Under Regulation 30 (LODR) - USFDA Inspection At Goa Formulation Facility -
2026-09-27 Closure of Trading Window -
2026-09-19 Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 -
2026-09-11 Extension Of The Exercise Period For The Options Granted And Vested Under Unichem Employee Stock Option Scheme 2018 -
2026-08-26 Significant Increase In The Volume Of Securities. -
2026-08-26 Clarification sought from Unichem Laboratories Ltd -
2026-08-12 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-11 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-11 Q1 Financial Statement Of FY 2026-2027 -
2026-08-11 Board Meeting Outcome for Outcome Of Board Meeting -
2026-07-29 Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 -
2026-07-28 Board Meeting Intimation for To Inter-Alia Consider And Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended 30Th June 2026. -
2026-07-10 Response To Clarification Sought On Price Movement -
2026-07-10 Clarification sought from Unichem Laboratories Ltd -
2026-07-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-06 General Announcemnets -
2026-07-06 Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015 -
2026-07-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-03 Notice Of 63Rd AGM - 11Th August 2026 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹531.45, within a 52-week range of ₹284.05 to ₹650.60. The P/E ratio is 12.62 and the P/B ratio is 1.42, with earnings per unit of ₹35.91. Market capitalisation stands at ₹3,767.06 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.